Recent News

• 12.09.2025 - Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System’s Convertible Dual Lumen Cannula Device and Method of Use
• 12.03.2025 - Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology
• 11.13.2025 - Inspira Completes Clinical Study for HYLA™ Blood Sensor – Ahead of Regulatory Submission
• 11.06.2025 - Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion
• 10.22.2025 - Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira’s Global Ecosystem

Recent Filings

• 12.09.2025 - EX-99.1 EX-99.1
• 12.09.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.03.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.03.2025 - EX-99.1 EX-99.1
• 11.25.2025 - F-3/A Registration statement by foreign private issuers
• 11.25.2025 - EX-99.1 EX-99.1
• 11.25.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.13.2025 - 144 Report of proposed sale of securities
• 11.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.13.2025 - EX-99.1 EX-99.1